XG-102

· Xigen SA

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for XG-102, covering 2012-04-04 to 2017-01-24. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of XG-102 in Reduction of Post-cataract Surgery Intraocular Inflammation [Phase 3]